Research Output per year
Fingerprint Dive into the research topics where Donald Small is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Protein-Tyrosine Kinases
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Hematopoietic Stem Cells
Medicine & Life Sciences
fms-Like Tyrosine Kinase 3
Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicine & Life Sciences
Stem Cells
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1982 2019
A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor
Argani, P., Zhang, L., Sung, Y. S., White, M. J., Miller, K., Hopkins, M., Small, D., Pratilas, C., Swanson, D., Dickson, B. & Antonescu, C. R., Jan 1 2019, (Accepted/In press) In : Genes Chromosomes and Cancer.Research output: Contribution to journal › Article
Perivascular Epithelioid Cell Neoplasms
Gene Fusion
Fluorescence In Situ Hybridization
Pediatrics
Kidney
Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3
Nagai, K., Hou, L., Li, L., Nguyen, B., Seale, T., Shirley, C., Ma, H., Levis, M. J., Ghiaur, G., Duffield, A. S. & Small, D., Aug 31 2018, In : Oncotarget. 9, 68, p. 32885-32899 15 p.Research output: Contribution to journal › Article
Protein-Tyrosine Kinases
Leukemia
Acute Myeloid Leukemia
Acute Promyelocytic Leukemia
Ubiquitination
Knock-In of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice
Annesley, C. E., Rabik, C., Duffield, A. S., Rau, R. E., Magoon, D., Li, L., Huff, V., Small, D., Loeb, D. M. & Brown, P. A., Oct 1 2018, In : Oncotarget. 9, 82, p. 35313-35326 14 p.Research output: Contribution to journal › Article
Myelodysplastic Syndromes
Wilms Tumor
Mutation
Neoplasms
Karyotype
Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase–driven leukemias and other malignancies
Bruner, J. K., Ma, H. S., Li, L., Qin, A. C. R., Rudek-Renaut, M., Jones, R. J., Levis, M. J., Pratz, K., Pratilas, C. & Small, D., Oct 15 2017, In : Cancer Research. 77, 20, p. 5554-5563 10 p.Research output: Contribution to journal › Article
Protein-Tyrosine Kinases
Tyrosine
Leukemia
Neoplasms
Acute Myeloid Leukemia
DOCK2: A novel FLT3/ITD leukemia drug target
Wu, M., Small, D. & Duffield, A. S., 2017, In : Oncotarget. 8, 51, p. 88253-88254 2 p.Research output: Contribution to journal › Editorial
Acute Myeloid Leukemia
Leukemia
Pharmaceutical Preparations